Tango Therapeutics (TNGX) Metrics: History & Chart

Tango Therapeutics, Inc.(TNGX)

Biotechnology · Boston, MA

$21.90-1.18 (-5.11%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.

Boston, MA

137 employees

www.tangotx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Malte Peters

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-5.02%
30D Total Return	+2.49%
YTD Total Return	+160.50%
1Y Total Return	+197.42%
3Y Total Return	+92.17%
5Y Total Return	+65.48%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+160.50%
2025	+186.73%
2024	-68.79%
2023	+36.55%
2022	-33.73%
2021	-4.37%
2020

CAGR TTM	+195.88%
CAGR 3Y	+24.32%
CAGR 5Y	+10.60%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

TNGX Valuation Metrics

TNGX Stock Price Metrics

TNGX Dividend Metrics

TNGX Growth Rate Metrics

TNGX Discounted Cash Flow Metrics

TNGX Returns By Period

TNGX Yearly Returns

TNGX Average Annual Returns By Period (CAGR)

TNGX Revenue Metrics

TNGX PE Ratio Metrics

TNGX PS Ratio Metrics

TNGX PB Ratio Metrics

TNGX Price to Free Cash Flow Ratio Metrics

TNGX Debt to Equity Ratio Metrics

TNGX PEG Ratio Metrics

TNGX FCF Yield

TNGX Earnings Yield

TNGX EBITDA Yield

TNGX OCF Yield

TNGX EV/EBIT Ratio Metrics

TNGX EV/EBITDA Ratio Metrics

TNGX EV/Assets Ratio Metrics

TNGX EV/Sales Ratio Metrics

TNGX Current Ratio Metrics

TNGX Quick Ratio Metrics

TNGX ROIC Metrics

TNGX Return on Assets Metrics

TNGX Return on Equity Metrics

TNGX Net Profit Margin Metrics

TNGX Gross Profit Margin Metrics

TNGX Tax Rate Metrics

PS Ratio	64.28
PS Ratio Avg TTM	43.40
PS Ratio Avg 3Y	21.40
Current VS TTM Avg	+48.12%
Current VS 3Y Avg	+200.40%
Current VS 5Y Avg	+225.61%

PB Ratio	3.38
PB Ratio Avg TTM	7.30
PB Ratio Avg 3Y	4.36
Current VS TTM Avg	-53.73%
Current VS 3Y Avg	-22.44%
Current VS 5Y Avg	+13.25%

PFCF Ratio	15.61
PFCF Ratio Avg TTM	14.65
PFCF Ratio Avg 3Y	14.65
Current VS TTM Avg	+6.52%
Current VS 3Y Avg	+6.52%
Current VS 5Y Avg	+6.52%

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.14
Debt/Equity Ratio Avg 3Y	0.16
Current VS TTM Avg	-77.33%
Current VS 3Y Avg	-80.35%
Current VS 5Y Avg	-75.71%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	6.41%
FCF Yield Avg TTM	6.81%
FCF Yield Avg 3Y	6.81%
Current VS TTM Avg	-5.87%
Current VS 3Y Avg	-5.87%
Current VS 5Y Avg	-5.87%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	2.93
Ev/Assets Ratio Avg TTM	5.84
Ev/Assets Ratio Avg 3Y	2.77
Current VS TTM Avg	-49.83%
Current VS 3Y Avg	+5.81%
Current VS 5Y Avg	+55.38%

Ev/Sales Ratio	58.46
Ev/Sales Ratio Avg TTM	41.61
Ev/Sales Ratio Avg 3Y	21.09
Current VS TTM Avg	+40.50%
Current VS 3Y Avg	+177.17%
Current VS 5Y Avg	+215.99%

Current Ratio	50.82
Current Ratio Avg TTM	21.63
Current Ratio Avg 3Y	7.27
Current VS TTM Avg	+134.97%
Current VS 3Y Avg	+599.57%
Current VS 5Y Avg	+498.76%

Quick Ratio	50.82
Quick Ratio Avg TTM	21.63
Quick Ratio Avg 3Y	7.27
Current VS TTM Avg	+134.97%
Current VS 3Y Avg	+599.57%
Current VS 5Y Avg	+498.76%

ROIC	(12.91%)
ROIC Avg 3Y	(41.13%)
ROIC Avg 5Y	(30.08%)
Current VS 3Y Avg	+68.62%
Current VS 5Y Avg	+57.09%
Current VS 10Y Avg	+56.69%

ROA	(11.52%)
ROA Avg TTM	(6.82%)
ROA Avg 3Y	(9.22%)
Current VS TTM Avg	-68.97%
Current VS 3Y Avg	-24.88%
Current VS 5Y Avg	-61.80%

ROE	(12.08%)
ROE Avg TTM	(47.90%)
ROE Avg 3Y	(45.49%)
Current VS TTM Avg	+74.78%
Current VS 3Y Avg	+73.44%
Current VS 5Y Avg	+69.69%

Net Profit Margin	(229.92%)
Net Profit Margin Avg TTM	(238.38%)
Net Profit Margin Avg 3Y	(363.69%)
Current VS TTM Avg	+3.55%
Current VS 3Y Avg	+36.78%
Current VS 5Y Avg	+28.52%

Gross Profit Margin	98.25%
Gross Pft Margin Avg TTM	36.07%
Gross Pft Margin Avg 3Y	96.43%
Current VS TTM Avg	+172.38%
Current VS 3Y Avg	+1.89%
Current VS 5Y Avg	+6.89%

Tax Rate	(0.06%)
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A